for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Medtronic PLC

MDT.N

Latest Trade

107.72USD

Change

-0.40(-0.37%)

Volume

70,845

Today's Range

107.71

 - 

108.60

52 Week Range

81.68

 - 

112.05

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
108.12
Open
108.45
Volume
70,845
3M AVG Volume
93.19
Today's High
108.60
Today's Low
107.71
52 Week High
112.05
52 Week Low
81.68
Shares Out (MIL)
1,341.67
Market Cap (MIL)
145,061.30
Forward P/E
19.44
Dividend (Yield %)
2.00

Next Event

Q2 2020 Medtronic PLC Earnings Release

Latest Developments

More

FDA Classifies Medtronic Sherpa Delivery Catheter Field Action Initiated In March 2019 As Class I Recall

U.S. FDA Says Medtronic Recalls 6 French Sherpa NX Active Guide Catheters

Medtronic Makes FDA Submission For Interstim Micro Neurostimulator And Surescan Mri Leads

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Medtronic PLC

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

Industry

Medical Equipment & Supplies

Contact Info

20 On Hatch, Hatch Street Lower

+353.1.4381700

http://www.medtronic.com/

Executive Leadership

Omar Syed Ishrak

Chairman of the Board, Chief Executive Officer

Karen L. Parkhill

Chief Financial Officer, Executive Vice President

Carol A. Surface

Chief Human Resource Officer, Senior Vice President

Michael J. Coyle

Executive Vice President, Group President - Cardiac and Vascular Group

Hooman C. Hakami

Executive Vice President and Group President of the Diabetes Group

Key Stats

2.04 mean rating - 25 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

29.7K

2018

30.0K

2019

30.6K

2020(E)

31.5K
EPS (USD)

2017

4.600

2018

4.770

2019

5.220

2020(E)

5.561
Price To Earnings (TTM)
33.05
Price To Sales (TTM)
4.73
Price To Book (MRQ)
2.88
Price To Cash Flow (TTM)
20.40
Total Debt To Equity (MRQ)
52.15
LT Debt To Equity (MRQ)
49.25
Return on Investment (TTM)
5.47
Return on Equity (TTM)
4.93

Latest News

Latest News

Israel grants $33 million to GE, Medtronic, Change Healthcare to boost R&D

Three multinational companies have received an Israeli government grant of 120 million shekels ($33 million) aimed at boosting the presence of large companies and establishing Israel as a hub in biotechnology and medicine.

Medtronic wins $472 million U.S. defense contract: Pentagon

Medtronic PLC <MDT.N> has been awarded a $472 million U.S. defense contract for cardiovascular products, the Pentagon said on Wednesday.

Medtronic beats estimates on cardio, diabetes gains

Medtronic Plc <MDT.N> topped analysts' estimates for profit in the fourth quarter as it kept a tight lid on costs and upped sales of its heart valves and insulin pumps, offsetting the impact of hurricane damage to production in Puerto Rico.

RPT-Medical device maker Medtronic reports 25.5 pct rise in profit

Medtronic Plc reported a 25.5 percent rise in quarterly profit on Thursday on higher demand for its heart devices.

Medical device maker Medtronic reports 25.5 pct rise in profit

Medtronic Plc reported a 25.5 percent rise in quarterly profit on Thursday on higher demand for its heart devices.

BRIEF-New Medtronic data shows blood pressure lowering effect of renal denervation

* NEW MEDTRONIC DATA SHOW SIGNIFICANT BLOOD PRESSURE LOWERING EFFECT OF RENAL DENERVATION IN PATIENTS TAKING ANTI-HYPERTENSIVE MEDICATION Source text for Eikon: Further company coverage:

BRIEF-Medtronic Begins U.S. Study To Evaluate Treatment Of Bifurcation Lesions In Patients With Coronary Artery Disease

* MEDTRONIC BEGINS U.S. STUDY OF DRUG-ELUTING STENTS TO EVALUATE TREATMENT OF BIFURCATION LESIONS IN PATIENTS WITH CORONARY ARTERY DISEASE Source text for Eikon: Further company coverage:

BRIEF-Mike Weinstein To Join Medtronic As Senior Vice President Of Strategy

* MIKE WEINSTEIN TO JOIN MEDTRONIC AS SENIOR VICE PRESIDENT OF STRATEGY Source text for Eikon: Further company coverage:

BRIEF-UK's CMA says Revoked Initial Enforcement Order On Completed Acquisition By Medtronic Of Animas Corp Assets

* UK'S CMA - HAS REVOKED INITIAL ENFORCEMENT ORDER MADE ON FEB 19 IN RELATION TO COMPLETED ACQUISITION BY MEDTRONIC PLC OF CERTAIN ASSETS OF ANIMAS CORP Source text (http://bit.ly/2jqGZ9X) Further company coverage:

BRIEF-Medtronic Announces New Paid Family Care Leave Benefits

* MEDTRONIC - EXPANDED PAID FAMILY LEAVE BENEFITS; ALL FULL-TIME, PART-TIME U.S. EMPLOYEES TO BE COVERED UNDER MEDTRONIC FAMILY CARE LEAVE POLICY Source text for Eikon: Further company coverage:

BRIEF-Medtronic Receives FDA Approval For Deep Brain Stimulation Therapy For Type Of Epilepsy

* MEDTRONIC RECEIVES FDA APPROVAL FOR DEEP BRAIN STIMULATION THERAPY FOR MEDICALLY REFRACTORY EPILEPSY

BRIEF-Medtronic Announces FDA Approval Of Infuse Bone Graft In New Spine Surgery Indications

* MEDTRONIC ANNOUNCES FDA APPROVAL OF INFUSE(TM) BONE GRAFT IN NEW SPINE SURGERY INDICATIONS USING PEEK INTERBODY IMPLANTS Source text for Eikon: Further company coverage:

Edward Lifesciences' heart valve sales in Europe disappoint, shares fall

Edwards Lifesciences Corp's <EW.N> first-quarter sales for transcatheter heart valves missed Wall Street targets on Tuesday, as the medical device maker lost market share in Europe to its rival, Medtronic Plc <MDT.N>.

BRIEF-Medtronic In.Pact Admiral Drug Coated Balloon Receives FDA Approval

* MEDTRONIC IN.PACT(TM) ADMIRAL(TM) DRUG COATED BALLOON RECEIVES FDA APPROVAL TO TREAT LONG SFA LESIONS

BRIEF-Arca Biopharma And Medtronic Extend Gencaro Clinical Trial Collaboration Agreement

* ARCA BIOPHARMA AND MEDTRONIC EXTEND GENCARO CLINICAL TRIAL COLLABORATION AGREEMENT

BRIEF-Medtronic Announces U.S. Launch Of Optisphere Embolization Spheres

* MEDTRONIC - ANNOUNCES U.S. LAUNCH OF OPTISPHERE EMBOLIZATION SPHERES, A RESORBABLE EMBOLIC PLATFORM DESIGNED FOR EMBOLIZATION OF HYPERVASCULAR TUMORS Source text for Eikon: Further company coverage:

BRIEF-Medtronic Expands Visualase MRI-Guided Laser Ablation System to Europe with CE Mark Approval

* MEDTRONIC EXPANDS VISUALASE(TM) MRI-GUIDED LASER ABLATION SYSTEM TO EUROPEAN MARKETS WITH CE MARK APPROVAL

BRIEF-UK's CMA Says Investigating Completed Acquisition By Medtronic Of Certain Assets Of Animas Corp

* CMA IS INVESTIGATING THE COMPLETED ACQUISITION BY MEDTRONIC PLC OF CERTAIN ASSETS OF ANIMAS CORPORATION Source text (http://bit.ly/2Ham0WD) Further company coverage:

BRIEF-Medtronic To Redeem About $1.2 Bln Of Medtronic Inc's Senior Notes

* MEDTRONIC PLC - INTENDS TO REDEEM ABOUT $1.2 BILLION OF MEDTRONIC, INC.'S SENIOR NOTES - SEC FILING

BRIEF-New Analyses Confirm Patients With Medtronic CRT Devices Experience Less Atrial Fibrillation, Are More Active

* NEW ANALYSES CONFIRM PATIENTS WITH MEDTRONIC CRT DEVICES EXPERIENCE LESS ATRIAL FIBRILLATION, ARE MORE ACTIVE Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up